111 – 120 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Physical performance, toxicity, and quality of life as assessed by the physician and the patient
- Contribution to journal › Article
-
Mark
Validering av ny prognostisk modell i lymfkörtelnegativ bröstcancer baserad på automatiskt utvärderade DNA flödescytometriska data
(2002) Svenska Läkaresällskapets Riksstämma
- Contribution to conference › Poster
- 2001
-
Mark
S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer
- Contribution to journal › Article
-
Mark
Image cytometric Auer class-I identifies a real low risk group among lymph node negative premenopausal breast cancer patients
- Contribution to journal › Published meeting abstract
-
Mark
Histological grade, its three components and flow cytometric S-phase as prognostic markers in premenopausal women with node negative breast cancer
- Contribution to journal › Published meeting abstract
-
Mark
DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase) : association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients
- Contribution to journal › Article
-
Mark
Timing of quality of life (QoL) assessments as a source of error in oncological trials
- Contribution to journal › Article
- 2000
-
Mark
Quantitative 201Tl SPET imaging in the follow-up of treatment for brain tumour: a sensitive tool for the early identification of response to chemotherapy?
- Contribution to journal › Article
-
Mark
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels
- Contribution to journal › Article
-
Mark
A randomised study of sector resection with and without radiotherapy for women with node-negative stage I and II breast cancer
- Contribution to journal › Published meeting abstract